@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-V85XJ7VZ-H skos:prefLabel "Oxepins"@en, "Oxépines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-V8B160F9-Z . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZRLD172S-B skos:prefLabel "Dibenzoxépines"@fr, "Dibenzoxepins"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-V8B160F9-Z . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-P1H7PF4C-5 skos:prefLabel "Produits pharmaceutiques favorisant le sommeil"@fr, "Sleep Aids, Pharmaceutical"@en ; a mesh:Descriptor, skos:Concept . jvr:-PVLL6K0M-3 skos:prefLabel "Antihistaminiques"@fr, "Histamine Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-XR0VST6Z-2 skos:prefLabel "Antidépresseurs tricycliques"@fr, "Antidepressive Agents, Tricyclic"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-V8B160F9-Z mesh:allowableQualifier jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-NB0XHT3S-N, jvr:-S0CS1X5R-5, jvr:-H7K65Q8S-Z, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-WK5F724J-1, jvr:-NFTHND7Q-8, jvr:-G4R176S9-J, jvr:-R0ZCQ8X6-J, jvr:-W6SQV79N-S, jvr:-BT300B3G-Q, jvr:-XV06LPML-W, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B, jvr:-M63HSDM7-1, jvr:-Q3979798-W, jvr:-T9HQD7ST-J, jvr:-NKM836P1-M, jvr:-FWD2BGQ0-9 ; skos:hiddenLabel "Mareen"@en, "Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5)"@en, "Sinequan"@en, "Doneurin"@en, "Aponal"@en, "Sinquan"@en, "Xepin"@en, "Quitaxon"@en, "Apo-Doxepin"@en, "Novo-Doxepin"@en, "Espadox"@en, "Doxepia"@en, "Prudoxin"@en, "Chlorhydrate de doxépine"@fr, "Doxepin Hydrochloride"@en, "Desidox"@en, "Doxepin-RPh"@en, "Doxepin beta"@en, "Deptran"@en, "Zonalon"@en ; mesh:pharmacologicalAction jvr:-XR0VST6Z-2, jvr:-PVLL6K0M-3, jvr:-P1H7PF4C-5 ; skos:prefLabel "Doxépine"@fr, "Doxepin"@en ; skos:broader jvr:-ZRLD172S-B, jvr:-V85XJ7VZ-H ; dc:modified "2016-05-31"^^xsd:date ; skos:altLabel "1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-"@fr, "1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-"@en, "1668-19-5"@en, "1668-19-5"@fr, "1229-29-4 (HCl, cis-trans (approximately 1:5) mixture)"@fr, "1229-29-4 (HCl, cis-trans (approximately 1:5) mixture)"@en, "5ASJ6HUZ7D"@en, "5ASJ6HUZ7D"@fr ; skos:inScheme jvr: ; skos:definition "A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors."@en ; a mesh:Descriptor, skos:Concept ; dc:established "1974-01-01"^^xsd:date ; dc:created "1999-01-01"^^xsd:date ; owl:sameAs . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .